Aphasia in Vascular and Degenerative Conditions: From Theory to Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: closed (1 April 2022) | Viewed by 18437
Special Issue Editors
Interests: post-stroke aphasia; primary progressive aphasia; aphasia in degenerative disorders; neuropsychiatric-associated disorders; neuroimaging; neurophysiology; biological markers; computer modeling; eye tracking; predictors of recovery; outcome measures; aphasia therapy; pharmacotherapy; non-invasive brain stimulation
Interests: post-stroke aphasia; primary progressive aphasia; aphasia in degenerative disorders; neuropsychiatric-associated disorders; neuroimaging; neurophysiology; biological markers; computer modeling; eye tracking; predictors of recovery; outcome measures; aphasia therapy; pharmacotherapy; non-invasive brain stimulation
Interests: post-stroke aphasia; primary progressive aphasia; aphasia in degenerative disorders; neuropsychiatric-associated disorders; neuroimaging; neurophysiology; biological markers; computer modeling; eye tracking; predictors of recovery; outcome measures; aphasia therapy; pharmacotherapy; non-invasive brain stimulation
Special Issue Information
Dear Colleagues,
Aphasia is a leading cause of disability and poor life quality in populations with stroke and neurodegenerative conditions. This disorder is multidimensional, affecting non-language domains and behavior (motivation, mood). In the last few decades, great advances have been achieved in understanding the neurobiology of language and in the diagnosis and treatment of aphasia. For example, research aiming to find biomarkers (behavioral profiles, genetic testing and neuroimaging) that aid prediction of aphasia recovery and/or treatment response is growing. Moreover, deficits in non-linguistic domains such as executive and attention functions, resulting from damage to widely distributed brain networks, can predict certain aspects of language recovery or treatment outcomes. Advances in the treatment of aphasia are also being obtained by applying neuroscience-based therapies used alone and in combination with pharmacological agents and non-invasive brain stimulation that heighten experience-dependent plasticity.
This Special Issue focuses on recent advances in aphasia spanning from theory to treatment. We are seeking publications covering the following topics: post-stroke aphasia, primary progressive aphasia, aphasia in degenerative disorders, neuropsychiatric disorders associated with aphasia, and studies of neuroimaging, neurophysiology, computer modeling, biomarkers, eye tracking, predictors of recovery, outcome measures, language rehabilitation, pharmacotherapy, and non-invasive brain stimulation applied aphasia.
Prof. Dr. Marcelo L. Berthier
Prof. Dr. Guadalupe Dávila
Dr. Diana Lopez-Barroso
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Post-stroke aphasia
- Primary progressive aphasia
- Aphasia therapy
- Pharmacotherapy
- Non-invasive brain stimulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
